Exosect Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 20

Employees

  • Latest Deal Type
  • M&A

  • Investors
  • 1

Exosect General Information

Description

Provider of a proprietary technology platform designed to offer enhanced delivery of biological and synthetic active ingredients. The company's platform enables the targeted delivery of synthetic and biological active ingredients, thereby catering to pesticide manufacturers to improve the delivery of their formulations and to overcome issues related to pest resistance, regulatory control and residues within the food chain.

Contact Information

Website
www.exosect.com
Formerly Known As
Jade Projects, X02, XO2
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Leylands Business Park
  • Colden Common, Hampshire
  • Winchester SO21 1TH
  • England, United Kingdom
Primary Industry
Agricultural Chemicals
Other Industries
Specialty Chemicals
Acquirer
Corporate Office
  • Leylands Business Park
  • Colden Common, Hampshire
  • Winchester SO21 1TH
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Exosect Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
18. Merger/Acquisition 14-May-2019 Completed Generating Revenue
17. Bankruptcy: Admin/Reorg 18-Oct-2018 Completed Bankruptcy: Admin/Reorg
16. Grant 13-Jul-2016 Completed Generating Revenue
15. Later Stage VC 04-Apr-2016 Completed Generating Revenue
14. Later Stage VC 16-Jan-2015 Completed Generating Revenue
13. Later Stage VC 12-Jul-2013 Completed Generating Revenue
12. Grant 25-Jan-2013 Completed Generating Revenue
11. Later Stage VC 01-Jan-2012 Completed Generating Revenue
10. Later Stage VC 29-Jun-2011 $325K $18.6M Completed Generating Revenue
9. Grant 31-Oct-2010 $397K $18.2M Completed Generating Revenue
To view Exosect’s complete valuation and funding history, request access »

Exosect Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
D Ordinary
C Ordinary
B2 Ordinary
B Ordinary 125,729 $0.014280 $49.98 $49.98 1x $49.98 19.58%
A Ordinary 67,503 $0.014280 $49.98 $49.98 1x $49.98 10.51%
To view Exosect’s complete cap table history, request access »

Exosect Patents

Exosect Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2019166662-A1 Composite particles Inactive 01-Mar-2018
GB-201702388-D0 Compositions for application to aerial parts of plants Inactive 14-Feb-2017
GB-2559625-A Compositions for application to aerial parts of plants Inactive 14-Feb-2017
US-20200000087-A1 Compositions for application to aerial parts of plants Pending 14-Feb-2017
WO-2018149816-A1 Compositions for application to aerial parts of plants Inactive 14-Feb-2017 A01N25/04
To view Exosect’s complete patent history, request access »

Exosect Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Exosect Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
ClearlySo Impact Investing Minority
Entrepreneurs Fund Family Office Minority
Gates Foundation Not-For-Profit Venture Capital
Hygea Health Holdings Holding Company Minority
Innovate UK Government
You’re viewing 5 of 9 investors. Get the full list »

Exosect FAQs

  • When was Exosect founded?

    Exosect was founded in 1999.

  • Where is Exosect headquartered?

    Exosect is headquartered in Winchester, United Kingdom.

  • What is the size of Exosect?

    Exosect has 20 total employees.

  • What industry is Exosect in?

    Exosect’s primary industry is Agricultural Chemicals.

  • Is Exosect a private or public company?

    Exosect is a Private company.

  • What is Exosect’s current revenue?

    The current revenue for Exosect is .

  • How much funding has Exosect raised over time?

    Exosect has raised $33.3M.

  • Who are Exosect’s investors?

    ClearlySo, Entrepreneurs Fund, Gates Foundation, Hygea Health Holdings, and Innovate UK are 5 of 9 investors who have invested in Exosect.

  • When was Exosect acquired?

    Exosect was acquired on 14-May-2019.

  • Who acquired Exosect?

    Exosect was acquired by Terramera.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process